HomeCompareRTGOF vs MRK

RTGOF vs MRK: Dividend Comparison 2026

RTGOF yields 5128.21% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RTGOF wins by $79569732907105.75M in total portfolio value
10 years
RTGOF
RTGOF
● Live price
5128.21%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79569732907105.80M
Annual income
$76,630,238,974,256,940,000.00
Full RTGOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RTGOF vs MRK

📍 RTGOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRTGOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RTGOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RTGOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RTGOF
Annual income on $10K today (after 15% tax)
$435,897.44/yr
After 10yr DRIP, annual income (after tax)
$65,135,703,128,118,395,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RTGOF beats the other by $65,135,703,128,118,390,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RTGOF + MRK for your $10,000?

RTGOF: 50%MRK: 50%
100% MRK50/50100% RTGOF
Portfolio after 10yr
$39784866453552.92M
Annual income
$38,315,119,487,128,480,000.00/yr
Blended yield
96.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RTGOF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RTGOF buys
0
MRK buys
0
No recent congressional trades found for RTGOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRTGOFMRK
Forward yield5128.21%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$79569732907105.80M$56.8K
Annual income after 10y$76,630,238,974,256,940,000.00$9,798.13
Total dividends collected$79371015555921.34M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RTGOF vs MRK ($10,000, DRIP)

YearRTGOF PortfolioRTGOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$523,521$512,820.51$11,206$366.19+$512.3KRTGOF
2$25,651,013$25,090,846.53$12,650$502.35+$25.64MRTGOF
3$1,176,399,845$1,148,953,261.06$14,407$694.19+$1176.39MRTGOF
4$50,504,527,129$49,245,779,294.25$16,585$967.82+$50504.51MRTGOF
5$2,029,919,943,175$1,975,880,099,147.06$19,342$1,363.89+$2029919.92MRTGOF
6$76,392,776,643,917$74,220,762,304,720.03$22,913$1,947.19+$76392776.62MRTGOF
7$2,692,188,100,364,169$2,610,447,829,355,177.00$27,662$2,823.89+$2692188100.34MRTGOF
8$88,858,048,683,110,320$85,977,407,415,720,670.00$34,159$4,173.35+$88858048683.08MRTGOF
9$2,747,190,591,447,524,000$2,652,112,479,356,595,700.00$43,337$6,308.80+$2747190591447.48MRTGOF
10$79,569,732,907,105,800,000$76,630,238,974,256,940,000.00$56,776$9,798.13+$79569732907105.75MRTGOF

RTGOF vs MRK: Complete Analysis 2026

RTGOFStock

ArtGo Holdings Limited, an investment holding company, primarily engages in the mining, processing, trading, and sale of marble stones and commodity trading businesses in the People's Republic of China. It operates in two segments, Marble Products and Others. The company offers marble slabs, standard cut to size marble, antique series, water jet, border series, and marble-related crafts for bathroom and tailor-made household products; and calcium carbonate products. It also provides cargo handling services; and wholesales and retails decorating materials and chemical products. In addition, the company is involved in the provision of technical services for stone processing; warehousing, logistics, and sale of mineral products; and mining investment and mining planting projects. The company was formerly known as ArtGo Mining Holdings Limited and changed its name to ArtGo Holdings Limited in March 2015. ArtGo Holdings Limited was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

Full RTGOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RTGOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RTGOF vs SCHDRTGOF vs JEPIRTGOF vs ORTGOF vs KORTGOF vs MAINRTGOF vs JNJRTGOF vs ABBVRTGOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.